Mansi L. Sharma

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications

SPRTN preserves RNA polymerase I transcription under genotoxic drug stress in lung adenocarcinoma.

SPRTN preserves RNA polymerase I transcription under genotoxic drug stress in lung adenocarcinoma.

Journal: Frontiers in oncology
Published: June 23, 2026

Anaplastic lymphoma kinase immunohistochemical positivity in high-grade pulmonary neuroendocrine carcinoma: an actionable signal or merely a shadow?

Anaplastic lymphoma kinase immunohistochemical positivity in high-grade pulmonary neuroendocrine carcinoma: an actionable signal or merely a shadow?

Journal: Journal of clinical pathology
Published: May 10, 2026

Mediastinal over-staging with PET-CT in tuberculosis-endemic locally advanced NSCLC: SUV threshold recalibration improves PET/EBUS concordance.

Mediastinal over-staging with PET-CT in tuberculosis-endemic locally advanced NSCLC: SUV threshold recalibration improves PET/EBUS concordance.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 31, 2026

Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North India.

Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North India.

Journal: Journal of gastrointestinal cancer
Published: October 15, 2025

First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.

First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.

Journal: Immunotherapy
Published: September 05, 2025

A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival.

A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival.

Journal: Oncology and therapy
Published: July 16, 2025

Mixed germ cell tumour in pregnancy: clinical insights and challenges.

Mixed germ cell tumour in pregnancy: clinical insights and challenges.

Journal: BMJ case reports
Published: June 22, 2025

Clinical insights: atezolizumab-induced myositis mimicking hepatic injury.

Clinical insights: atezolizumab-induced myositis mimicking hepatic injury.

Journal: BMJ case reports
Published: June 17, 2025

Primary pleural Müllerian origin tumour: a clinical perspective.

Primary pleural Müllerian origin tumour: a clinical perspective.

Journal: BMJ case reports
Published: April 25, 2025

Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.

Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.

Journal: Lung India : official organ of Indian Chest Society
Published: March 12, 2025

NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy.

NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy.

Journal: Journal of translational medicine
Published: March 04, 2025

Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort.

Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort.

Journal: JCO global oncology
Published: January 08, 2025
Showing 1-12 of 61

Last Updated: 09/26/2026